Published in Journal of Clinical Oncology, 2022 | Abstract #3019, ASCO
This study showcases the use of artificial intelligence (AI) to predict homologous recombination deficiency (HRD) directly from histopathology images. The research demonstrates the potential of AI-enabled image analysis to serve as a non-invasive, rapid screening tool for HRD status—helping guide treatment decisions in oncology with greater speed and scalability.
Authors: Gowhar Shafi, Shivamurthy P M, Anand Ulle, Krithika Srinivasan, Aravindan Vasudevan, Vikas Jadhav, Sujit Joshi, Nirmal Vivek Raut, Jayant Khandare, Mohan Uttarwar, Kenneth Joel Bloom.